SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-004258
Filing Date
2023-01-09
Accepted
2023-01-09 09:06:58
Documents
15
Period of Report
2023-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d309038d8k.htm   iXBRL 8-K 62365
2 EX-2.1 d309038dex21.htm EX-2.1 751813
3 EX-99.1 d309038dex991.htm EX-99.1 18047
7 GRAPHIC g309038g0109063951892.jpg GRAPHIC 1841
  Complete submission text file 0001193125-23-004258.txt   1169497

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cinc-20230108.xsd EX-101.SCH 2834
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cinc-20230108_lab.xml EX-101.LAB 18736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cinc-20230108_pre.xml EX-101.PRE 11696
9 EXTRACTED XBRL INSTANCE DOCUMENT d309038d8k_htm.xml XML 3452
Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41201 | Film No.: 23516849
SIC: 2834 Pharmaceutical Preparations